Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Merck
Federal Trade Commission
Cantor Fitzgerald
Medtronic
Johnson and Johnson
Cerilliant
McKesson
QuintilesIMS

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076570

« Back to Dashboard

NDA 076570 describes TRIMETHOBENZAMIDE HYDROCHLORIDE, which is a drug marketed by Gavis Pharms, Sun Pharm Industries, Hospira, Luitpold, Smith And Nephew, Solopak, and Watson Labs, and is included in ten NDAs. It is available from eight suppliers. Additional details are available on the TRIMETHOBENZAMIDE HYDROCHLORIDE profile page.

The generic ingredient in TRIMETHOBENZAMIDE HYDROCHLORIDE is trimethobenzamide hydrochloride. There are six drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the trimethobenzamide hydrochloride profile page.
Summary for 076570
Tradename:TRIMETHOBENZAMIDE HYDROCHLORIDE
Applicant:Sun Pharm Industries
Ingredient:trimethobenzamide hydrochloride
Patents:0
Therapeutic Class:Antiemetics
Formulation / Manufacturing:see details
Pharmacology for NDA: 076570
Physiological EffectEmesis Suppression
Suppliers and Packaging for NDA: 076570
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRIMETHOBENZAMIDE HYDROCHLORIDE trimethobenzamide hydrochloride CAPSULE;ORAL 076570 ANDA Rebel Distributors Corp. 21695-448 E 21695-448-10
TRIMETHOBENZAMIDE HYDROCHLORIDE trimethobenzamide hydrochloride CAPSULE;ORAL 076570 ANDA Lake Erie Medical DBA Quality Care Products LLC 35356-473 E 35356-473-00

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength300MG
Approval Date:Aug 28, 2003TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
UBS
Covington
Queensland Health
QuintilesIMS
Chinese Patent Office
Fuji
Accenture
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot